[go: up one dir, main page]

SG77246A1 - Intranasal formulations for treating sexual disorders - Google Patents

Intranasal formulations for treating sexual disorders

Info

Publication number
SG77246A1
SG77246A1 SG1999002935A SG1999002935A SG77246A1 SG 77246 A1 SG77246 A1 SG 77246A1 SG 1999002935 A SG1999002935 A SG 1999002935A SG 1999002935 A SG1999002935 A SG 1999002935A SG 77246 A1 SG77246 A1 SG 77246A1
Authority
SG
Singapore
Prior art keywords
sexual disorders
treating sexual
intranasal formulations
intranasal
formulations
Prior art date
Application number
SG1999002935A
Other languages
English (en)
Inventor
Anne Billotte
Peter James Dunn
Brian Thomas Henry
Peter Vallance Marshall
Joanna Jayne Woods
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9813452.1A external-priority patent/GB9813452D0/en
Priority claimed from GBGB9820837.4A external-priority patent/GB9820837D0/en
Priority claimed from GBGB9903177.5A external-priority patent/GB9903177D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of SG77246A1 publication Critical patent/SG77246A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1999002935A 1998-06-22 1999-06-17 Intranasal formulations for treating sexual disorders SG77246A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813452.1A GB9813452D0 (en) 1998-06-22 1998-06-22 Pharmaceutical formulations
GBGB9820837.4A GB9820837D0 (en) 1998-09-24 1998-09-24 Pharmaceutical formulations
GBGB9903177.5A GB9903177D0 (en) 1999-02-13 1999-02-13 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SG77246A1 true SG77246A1 (en) 2000-12-19

Family

ID=27269368

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999002935A SG77246A1 (en) 1998-06-22 1999-06-17 Intranasal formulations for treating sexual disorders

Country Status (40)

Country Link
US (2) US20020040139A1 (is)
EP (1) EP0967214B1 (is)
JP (1) JP3263379B2 (is)
KR (1) KR100345824B1 (is)
AP (1) AP1178A (is)
AR (1) AR016993A1 (is)
AT (1) ATE269866T1 (is)
AU (1) AU746865B2 (is)
BG (1) BG64372B1 (is)
BR (1) BR9903273A (is)
CA (1) CA2275554C (is)
CZ (1) CZ294856B6 (is)
DE (1) DE69918222T2 (is)
DK (1) DK0967214T3 (is)
DZ (1) DZ2826A1 (is)
EA (1) EA001903B1 (is)
ES (1) ES2221733T3 (is)
GT (1) GT199900095A (is)
HN (1) HN1999000096A (is)
HR (1) HRP990195B1 (is)
HU (1) HUP9902076A3 (is)
ID (1) ID23554A (is)
IL (1) IL130539A0 (is)
IS (1) IS5085A (is)
MA (1) MA25089A1 (is)
MY (1) MY117967A (is)
NO (1) NO317365B1 (is)
NZ (1) NZ336382A (is)
OA (1) OA11069A (is)
PA (1) PA8476301A1 (is)
PE (1) PE20000702A1 (is)
PT (1) PT967214E (is)
SG (1) SG77246A1 (is)
SI (1) SI0967214T1 (is)
SK (1) SK284574B6 (is)
TN (1) TNSN99129A1 (is)
TR (1) TR199901444A2 (is)
TW (1) TWI223598B (is)
UA (1) UA59385C2 (is)
YU (1) YU29699A (is)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
CA2391968A1 (en) * 1999-11-18 2001-05-25 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE10118305A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Zusammensetzungen zur nasalen Applikation
WO2002094219A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of erectile dysfunction drugs through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US6737042B2 (en) 2001-05-24 2004-05-18 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8673360B2 (en) * 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
ES2339577T3 (es) 2004-10-18 2010-05-21 Polymun Scientific Immunbiologische Forschung Gmbh Composicion liposomal que contiene un principio activo para la relajacion de la musculatura lisa, preparacion de dicha composicion y su uso terapeutico.
WO2006094924A2 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
EP2366393B1 (en) 2005-04-19 2013-08-07 Takeda GmbH Roflumilast for the treatment of pulmonary hypertension
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
JP2008518041A (ja) * 2005-08-29 2008-05-29 テバ ファーマシューティカル インダストリーズ リミティド 双峰性粒度分布を有する固体微粒子タダラフィル
GB0526283D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Compositions
GB0606234D0 (en) * 2006-03-29 2006-05-10 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
CN101668544B (zh) * 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
US20110033506A1 (en) * 2008-02-08 2011-02-10 Adel Penhasi Combination dosage form of low-dose modafinil and low-dose sildenafil
EP2271347B1 (en) 2008-03-28 2016-05-11 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
KR101306537B1 (ko) 2008-06-04 2013-09-09 콜게이트-파아므올리브캄파니 캐비테이션 시스템을 가진 구강 관리기구
WO2009152344A2 (en) * 2008-06-11 2009-12-17 Comgenrx, Inc. Combination therapy using phosphodiesterase inhibitors
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
US8827946B2 (en) * 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
NZ603173A (en) 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
JP5840201B2 (ja) 2010-05-10 2016-01-06 ユーロ−セルティーク エス．エイ． 活性剤を負荷した顆粒と追加の活性剤の組合せ
CN103796656A (zh) 2011-06-14 2014-05-14 哈尔生物药投资有限责任公司 苯二氮卓的投与
CN102952138B (zh) * 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
EP2903619B1 (en) * 2012-10-05 2019-06-05 Robert I. Henkin Phosphodiesterase inhibitors for treating taste and smell disorders
CA2881144A1 (en) * 2012-11-09 2014-05-09 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
US20160030435A1 (en) * 2013-03-15 2016-02-04 Robert I HENKIN Phosphodiesterase inhibitor treatment
DE112014005175T5 (de) 2013-11-13 2016-07-21 Euro-Celtique S.A. Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom
EP3108245B1 (en) 2014-02-18 2020-07-22 Robert I. Henkin Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
NO2723977T3 (is) 2014-03-19 2018-03-10
CA2994709A1 (en) * 2015-08-03 2017-02-09 Synergistic Therapeutics, Llc Sexual dysfunction therapeutic gel
KR20190082803A (ko) * 2016-10-31 2019-07-10 수다 리미티드 점막의 활성 제제 전달
JP7143335B2 (ja) * 2017-03-02 2022-09-28 ダッチ・リニューアブル・エナジー・ビー．ブイ． 生理活性物質の鼻腔内投与
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
SG11202006080SA (en) 2017-12-26 2020-07-29 Ftf Pharma Private Ltd Liquid oral formulations for pde v inhibitors
KR102852740B1 (ko) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. 전기적 응축 에어로졸 디바이스
EP3781191A4 (en) * 2018-04-16 2022-01-19 Barista Mist Pty Ltd CAFFEINE COMPOSITIONS AND METHODS OF USE
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания
WO2022026762A1 (en) * 2020-07-29 2022-02-03 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
PE22798A1 (es) * 1995-11-20 1998-05-11 Lilly Co Eli Inhibidor de proteina quinasa c
IL132993A0 (en) * 1997-05-29 2001-03-19 Mochida Pharm Co Ltd Therapeutic agent for erection failure
DK1035833T3 (da) * 1997-12-02 2006-01-09 Archimedes Dev Ltd Sammensætning til nasal indgivelse
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
HUP9902076A2 (hu) 2000-05-28
CA2275554A1 (en) 1999-12-22
AU3579499A (en) 2000-01-06
AP9901585A0 (en) 1999-06-30
HRP990195A2 (en) 2000-02-29
EA199900487A2 (ru) 1999-12-29
US20020040139A1 (en) 2002-04-04
IS5085A (is) 1999-12-23
PE20000702A1 (es) 2000-08-16
HU9902076D0 (en) 1999-08-30
CA2275554C (en) 2003-06-03
PT967214E (pt) 2004-08-31
EA199900487A3 (ru) 2000-04-24
DZ2826A1 (fr) 2003-12-01
UA59385C2 (uk) 2003-09-15
BG103510A (en) 2000-01-31
YU29699A (sh) 2003-02-28
HN1999000096A (es) 2000-12-03
JP3263379B2 (ja) 2002-03-04
HUP9902076A3 (en) 2002-03-28
SK81999A3 (en) 2001-01-18
NO993051L (no) 1999-12-23
AP1178A (en) 2003-06-30
CZ294856B6 (cs) 2005-03-16
BG64372B1 (bg) 2004-12-30
NZ336382A (en) 1999-11-29
TR199901444A2 (xx) 2000-01-21
DE69918222D1 (de) 2004-07-29
MY117967A (en) 2004-08-30
TNSN99129A1 (fr) 2005-11-10
TWI223598B (en) 2004-11-11
US20030158206A1 (en) 2003-08-21
NO993051D0 (no) 1999-06-21
MA25089A1 (fr) 2000-12-31
EP0967214A1 (en) 1999-12-29
ATE269866T1 (de) 2004-07-15
NO317365B1 (no) 2004-10-18
GT199900095A (es) 2000-12-13
BR9903273A (pt) 2000-05-09
CZ9902257A3 (cs) 2000-11-15
SK284574B6 (sk) 2005-06-02
EA001903B1 (ru) 2001-10-22
AR016993A1 (es) 2001-08-01
KR20000006310A (ko) 2000-01-25
KR100345824B1 (ko) 2002-07-24
JP2000034232A (ja) 2000-02-02
AU746865B2 (en) 2002-05-02
IL130539A0 (en) 2000-06-01
EP0967214B1 (en) 2004-06-23
DK0967214T3 (da) 2004-09-27
DE69918222T2 (de) 2005-07-28
ES2221733T3 (es) 2005-01-01
OA11069A (en) 2002-03-13
SI0967214T1 (en) 2004-10-31
PA8476301A1 (es) 2000-09-29
HRP990195B1 (en) 2003-04-30
ID23554A (id) 2000-05-04

Similar Documents

Publication Publication Date Title
SG77246A1 (en) Intranasal formulations for treating sexual disorders
AU2001238472A1 (en) Method for treating parathyroid disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
IL141263A0 (en) Methods for treatment of neurological disorders
TW524114U (en) Massager
GB9908175D0 (en) Method of treating neurological disorders
EP1207874A4 (en) METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES
GB2348834B (en) Spray apparatus
PL345769A1 (en) Triazolopyridines for the treatment of thrombosis disorders
PL341392A1 (en) Triazinic compounds for treating cns disorders
AU2001288792A1 (en) Method of treating neurologic disorders
IL142589A0 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
HUP0102886A3 (en) Treatment of anxiety disorders
SI1468686T1 (sl) S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
ZA994077B (en) Intranasal formulations for treating sexual disorders.
AU2001272902A1 (en) Treating musculoskeletal disorders using lp85 and analogs thereof
SI1049672T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
SI1049670T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
AU1167P (en) Treat xTriticosecale
GB9824714D0 (en) Neurological disorders
GB9824715D0 (en) Neurological disorders
GB9802921D0 (en) Sexual aid
GB9805982D0 (en) Sexual aid
TW394131U (en) Improvement of handtool for roller skate